Since graduating in 1994 with a juris doctor from the Massachusetts School of Law, Boston-based attorney Edward Cerruti has gained admittance to the Massachusetts Bar and the United States District Court. Outside of his professional responsibilities, Edward Cerruti is a charitable donor to the ALS Association.
The ALS Association funds research into combating amyotrophic lateral sclerosis (ALS), which is also known as Lou Gehrig’s disease. One recipient of its funding is Dr. Steven Finkbeiner. A researcher at the Gladstone Institutes, a nonprofit medical research organization in San Francisco, Dr. Finkbeiner is currently working on an automated microscopy system called Brain Bot, which will change how scientists study cells in a dish.
Recognizing the high value of this cutting-edge technology, the ALS Association is funding Dr. Finkbeiner through a partnership, referred to as the Neuro Collaborative, of three leading laboratories in California. The Brain Bot works by assigning a unique, IP address-like code to each cell to monitor the cell over time. Of particular interest is the ability of the technology to track the health of motor neurons whose degradation leads to the ALS disease.
